HROC103 T0 M1 Cells
US$ 800,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | This is one of a series of cell lines which have been established by PD Dr. Michael Linnebacher from a PDTx (Patient-derived Tumor xenograft) since 2006. |
|---|---|
| Organismo | Human |
| Tecido | Colorectal, Established from a PDx (patient-derived xenograft) of primary CRC tissue (Colon ascendens, TNM stage T2N1M0R0L0V0, grade G2, Lk(n) + 2, ∑ Lk(n) 23). |
| Doença | Adenocarcinoma |
| Local da metástase | Regional lymph node involvement (TNM N1; Lk(n)+2 of 23 examined); no distant metastasis (M0) |
| Aplicações | Colorectal cancer research; CRC biology; PDx-derived cell line research; drug sensitivity and targeted therapy evaluation; p53/KRAS mutant CRC modeling; MSS CRC immunology; patient-matched HROC biobank studies |
| Sinônimos | HROC103 |
Características
| Idade | 44 years |
|---|---|
| Gênero | Male |
| Etnia | Caucasian |
| Morfologia | Small cells in colonies |
| Tipo de célula | Epithelial |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | HROC103 T0 M1 (Cytion catalog number 300802) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_1D10 |
| Situação em relação aos OGMs | No genetic modification; wildtype patient-derived CRC cell line established from a patient-derived xenograft by PD Dr. Linnebacher |
Dados biomoleculares
| Status de ploidia | Aneuploid |
|---|---|
| Status da MSI | MSS |
| Perfil mutacional | P53 mut, APC mut, K-RasG12VA, N-Raswt, H-Raswt, PIK3CAwt, B-Rafwt |
Manuseio
| Meio de cultura | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Tempo de duplicação | 30 hours |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Proporção de divisão | 1 to 3 |
| Densidade de semeadura | 2 x 104 cells/cm2 |
| Renovação de fluidos | Every 3 to 5 days |
| Recuperação pós-degelo | Few days |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|